Substituted quinazolines for inhibiting kinase activity
US-12403145-B2 · Sep 2, 2025 · US
This page is not indexed by search engines while we improve data quality.
Neupharma Inc — Physics
Neupharma Inc holds 27 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Neupharma Inc |
| Technology | Physics |
| Patents in slice | 27 |
| Recent patents in slice | 3 |
| First year | 2015 |
| Last year | 2025 |
Representative patents
Notable publications linking Neupharma Inc to Physics.
Substituted quinazolines for inhibiting kinase activity
US-12403145-B2 · Sep 2, 2025 · US
Substituted quinazolines for inhibiting kinase activity
US-2024197752-A1 · Jun 20, 2024 · US
Substituted quinazolines for inhibiting kinase activity
US-2024197752-A1 · Jun 20, 2024 · US
Substituted quinazolines for inhibiting kinase activity
US-11865120-B2 · Jan 9, 2024 · US
Recent filings
Latest patents from Neupharma Inc in Physics.
Substituted quinazolines for inhibiting kinase activity
US-12403145-B2 · Sep 2, 2025 · US
Substituted quinazolines for inhibiting kinase activity
US-12403145-B2 · Sep 2, 2025 · US
Substituted quinazolines for inhibiting kinase activity
US-2024197752-A1 · Jun 20, 2024 · US
Substituted quinazolines for inhibiting kinase activity
US-2024197752-A1 · Jun 20, 2024 · US
Substituted quinazolines for inhibiting kinase activity
US-11865120-B2 · Jan 9, 2024 · US
Related pages
Navigate to parent entity pages.